Philips has announced plans to invest more than $150m in U.S. manufacturing and research and development, reinforcing its commitment to expand production of AI-powered health technologies.
Key takeaways: $150m+ in new U.S. investment targets manufacturing and R&D to scale AI-enabled health technologies. Reedsville, PA and Plymouth, MN expansions boost ultrasound production, software customization, clinician training—and…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login

